![Kevin Laliberte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Laliberte served as the Executive Vice President-Product Strategy at Axsome Therapeutics, Inc. and as the Senior Vice President-Product Development at Dova Pharmaceuticals, Inc. He holds a doctorate degree from the University of Michigan.
| Sociétés | Poste | Fin |
|---|---|---|
| AXSOME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| DOVA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
